GlaxoSmithKline to pay $20 million to settle U.S. foreign bribery case

By Sarah N. Lynch WASHINGTON (Reuters) - GlaxoSmithKline Plc will pay $20 million to settle civil charges that it masked bribes to foreign officials in China by disguising them as legitimate travel, entertainment and marketing expenses, U.S. regulators said on Friday. The pharmaceutical company agreed to settle the case with the Securities and Exchange Commission without admitting or denying any wrongdoing. In a statement, the company said it had cooperated with the SEC and it had received credi